M&A Deal Summary |
|
---|---|
Date | 2022-07-26 |
Target | Palamedrix |
Sector | Life Science |
Buyer(s) | SomaLogic |
Deal Type | Add-on Acquisition |
Deal Value | 35M USD |
SEARCH BY
Try For Free 7-Day Free Trial
SomaLogic seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s precise, proprietary, and personalized measurement of important changes in an individual’s proteins over time. SomaLogic was founded in 2000 and is based in Boulder, Colorado.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (California) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2022) | 1 of 1 |
Size (of disclosed) | 1 of 1 |